Sanofi Consumer Healthcare India Limited Stock Price Today (NSE: SANOFICONR)
Sanofi Consumer Healthcare India Limited
Fundamental Score
Sanofi Consumer Healthcare India Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sanofi Consumer Healthcare India Limited share price today is ₹3990.40, down 1.60% on NSE/BSE as of 16 September 2026. Sanofi Consumer Healthcare India Limited (SANOFICONR) is a Mid-cap company in the Pharmaceuticals sector with a market capitalisation of ₹9.18K (Cr). The 52-week high for SANOFICONR share price is ₹5357.00 and the 52-week low is ₹3971.00. At a P/E ratio of 34.55x, SANOFICONR is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 73.09% and a debt-to-equity ratio of 0.00.
Sanofi Consumer Healthcare India Limited Share Price Chart — NSE/BSE Historical Performance
Sanofi Consumer Healthcare India Limited share price chart: -9.55% return over the past month. 52-week high ₹5357.00, 52-week low ₹3971.00.
Sanofi Consumer Healthcare India Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹4012.10 | ₹4039.30 | ₹3971.00 | ₹3990.40 | 1.97K (Cr) | |
| ₹4023.40 | ₹4112.00 | ₹3978.00 | ₹4055.30 | 7.74K (Cr) | |
| ₹4099.00 | ₹4113.50 | ₹4001.10 | ₹4023.40 | 4.40K (Cr) | |
| ₹4046.70 | ₹4180.00 | ₹4025.00 | ₹4089.60 | 4.99K (Cr) | |
| ₹4099.80 | ₹4099.80 | ₹4033.00 | ₹4049.50 | 11.92K (Cr) | |
| ₹4106.00 | ₹4129.90 | ₹4040.50 | ₹4075.60 | 2.77K (Cr) | |
| ₹4210.00 | ₹4210.00 | ₹4075.00 | ₹4106.00 | 2.79K (Cr) | |
| ₹4205.30 | ₹4234.90 | ₹4108.00 | ₹4201.70 | 6.43K (Cr) | |
| ₹4181.00 | ₹4287.90 | ₹4145.00 | ₹4205.40 | 7.44K (Cr) | |
| ₹4140.00 | ₹4220.30 | ₹4070.10 | ₹4182.40 | 4.64K (Cr) |
Sanofi Consumer Healthcare India Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹4125.00 | ₹4287.90 | ₹3971.00 | ₹3990.40 | -3.26% | |
| ₹4619.00 | ₹4659.00 | ₹4122.10 | ₹4140.20 | -10.37% | |
| ₹4622.60 | ₹4927.00 | ₹4500.30 | ₹4611.20 | -0.25% | |
| ₹4530.28 | ₹4921.90 | ₹4451.50 | ₹4597.00 | +1.47% | |
| ₹4760.00 | ₹5255.00 | ₹4431.80 | ₹4518.96 | -5.06% | |
| ₹4350.00 | ₹4955.60 | ₹4302.20 | ₹4763.90 | +9.51% | |
| ₹4354.50 | ₹4609.80 | ₹4000.50 | ₹4298.20 | -1.29% | |
| ₹4287.80 | ₹4811.00 | ₹3975.00 | ₹4489.30 | +4.70% | |
| ₹4479.40 | ₹4605.60 | ₹3990.00 | ₹4246.80 | -5.19% | |
| ₹4699.70 | ₹4874.10 | ₹4382.20 | ₹4519.90 | -3.83% | |
| ₹4900.00 | ₹5078.00 | ₹4592.30 | ₹4659.70 | -4.90% | |
| ₹4767.70 | ₹4899.00 | ₹4556.00 | ₹4842.60 | +1.57% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Sanofi Consumer Healthcare India Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sanofi Consumer Healthcare India Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SANOFICONR across key market metrics for learning purposes.
Positive Indicators
7 factors identified
Strong Return on Equity (73.09%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (89.61%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (161.15x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Healthy Liquidity Position (Current Ratio: 3.00)
Observation: Strong short-term liquidity to meet obligations.
Analysis: Current ratio >1.5 indicates good working capital management.
Balanced Promoter Holding (71.27%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
1 factors identified
High Price-to-Book Ratio (33.66x)
Observation: Trading at significant premium to book value.
Analysis: High P/B ratios may indicate overvaluation relative to asset base.
Sanofi Consumer Healthcare India Limited vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Sanofi Consumer Healthcare India Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Sanofi Consumer Healthcare India LimitedSanofi Consumer...Selected✓ SANOFICONR • 544250 | 52.2/100 | ₹3990.40₹3990 | ₹9177.92₹9177.92 | 34.55Average 34.6 Average | 73.09%Excellent 73.09% Excellent | 89.61%Excellent 89.61% Excellent | 0.00Excellent 0.0 Excellent | — — | — — | 1.66% |
Sun Pharmaceutical Industries LimitedSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1876.50₹1877 | ₹450228.65₹450228.65 | 37.23Average 37.2 Average | 14.74%Average 14.74% Average | 19.31%Good 19.31% Good | 0.05Excellent 0.0 Excellent | 31.64%Excellent 31.64% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divi's Laboratories LimitedDivi's Laborato... DIVISLAB • 532488 | 56.3/100 | ₹9456.00₹9456 | ₹250584.00₹250584.00 | 85.80Average 85.8 Average | 16.19%Good 16.19% Good | 20.38%Excellent 20.38% Excellent | 0.00Excellent 0.0 Excellent | 5.29%Good 5.29% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LimitedTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹4927.00₹4927 | ₹166759.24₹166759.24 | 78.71Average 78.7 Average | 27.07%Excellent 27.07% Excellent | 14.09%Average 14.09% Average | 1.76Average 1.8 Average | 11.56%Good 11.56% Good | 11.80%Good 11.80% Good | 0.76% |
Zydus Lifesciences LimitedZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1138.70₹1139 | ₹113642.26₹113642.26 | 25.38Average 25.4 Average | 19.74%Good 19.74% Good | 21.77%Excellent 21.77% Excellent | 0.43Excellent 0.4 Excellent | 18.76%Excellent 18.76% Excellent | 12.45%Good 12.45% Good | 0.09% |
Cipla LimitedCipla Limited... CIPLA • 500087 | 40.2/100 | ₹1370.50₹1371 | ₹110715.84₹110715.84 | 32.83Average 32.8 Average | 11.82%Average 11.82% Average | 15.67%Good 15.67% Good | 0.01Excellent 0.0 Excellent | 10.03%Good 10.03% Good | 8.01%Good 8.01% Good | 0.90% |
Laurus Labs LimitedLaurus Labs Lim... LAURUSLABS • 540222 | 34.1/100 | ₹1941.50₹1942 | ₹104889.54₹104889.54 | 95.83Average 95.8 Average | 18.19%Good 18.19% Good | 21.35%Excellent 21.35% Excellent | 0.45Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Aurobindo Pharma LimitedAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1685.60₹1686 | ₹96989.42₹96989.42 | 26.34Average 26.3 Average | 9.94%Poor 9.94% Poor | 14.54%Average 14.54% Average | 0.20Excellent 0.2 Excellent | -8.07%Poor -8.07% Poor | 6.32%Good 6.32% Good | 0.26% |
Lupin LimitedLupin Limited... LUPIN • 500257 | 83.4/100 | ₹2103.00₹2103 | ₹96159.68₹96159.68 | 17.38Average 17.4 Average | 26.90%Excellent 26.90% Excellent | 31.80%Excellent 31.80% Excellent | 0.26Excellent 0.3 Excellent | 34.39%Excellent 34.39% Excellent | 13.02%Good 13.02% Good | 0.72% |
Dr. Reddy's Laboratories LimitedDr. Reddy's Lab... DRREDDY • 500124 | 41/100 | ₹1144.60₹1145 | ₹95574.10₹95574.10 | 29.58Average 29.6 Average | 11.75%Average 11.75% Average | 14.80%Average 14.80% Average | 0.17Excellent 0.2 Excellent | 16.54%Excellent 16.54% Excellent | 12.09%Good 12.09% Good | 0.65% |
Mankind Pharma LimitedMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2276.70₹2277 | ₹94027.71₹94027.71 | 46.00Average 46.0 Average | 12.49%Average 12.49% Average | 13.56%Average 13.56% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Limited share price450228.65 Cr
- Divi's Laboratories Limited share price250584.00 Cr
- Torrent Pharmaceuticals Limited share price166759.24 Cr
- Zydus Lifesciences Limited share price113642.26 Cr
- Cipla Limited share price110715.84 Cr
Sanofi Consumer Healthcare India Limited PE Ratio History
Historical price-to-earnings ratio for SANOFICONR — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹78.59 | ₹4927.40 | 62.7x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Sanofi Consumer Healthcare India Limited Dividend History
Annual cash dividends paid by SANOFICONR — dividend yield 1.66%
| Financial Year | Dividends Paid (₹ Cr) |
|---|---|
| FY 2024 | ₹115.20 Cr |
Cash dividends from annual cash flow statements. Past dividends do not guarantee future payments. Not investment advice.
Sanofi Consumer Healthcare India Limited Quarterly Performance
Latest quarterly metrics for SANOFICONR — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
6.70%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
13.34%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
N/A
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
N/A
Compounded annual net profit growth over 5 years
Sanofi Consumer Healthcare India Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SANOFICONR — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Sanofi Consumer Healthcare India Limited Financial Statements
Annual income statement, balance sheet and cash flow for Sanofi Consumer Healthcare India Limited (SANOFICONR) — sourced from NSE/BSE filings.
Financial Results & Statements
Latest quarterly, annual and period-wise financial data for Sanofi Consumer Healthcare India Limited
About SANOFICONR (Sanofi Consumer Healthcare India Limited)
Sanofi Consumer Healthcare Inc. is a dynamic player in the global over-the-counter (OTC) pharmaceutical landscape, dedicated to empowering individuals to proactively manage their h...ealth and well-being. With a commitment to scientific innovation and consumer-centric solutions, the company develops, manufactures, and markets a diverse portfolio of trusted brands. These brands address a broad spectrum of everyday health needs, including digestive health, pain management, allergy relief, cough, cold, and flu remedies, as well as vitamins, minerals, and supplements. Sanofi Consumer Healthcare Inc. operates with a vision to be a reliable partner in self-care, making quality healthcare accessible and convenient for consumers worldwide. Leveraging cutting-edge research and development, Sanofi Consumer Healthcare Inc. continuously strives to enhance its existing product lines and introduce innovative solutions to meet evolving consumer demands. The company's product development strategy is driven by a deep understanding of consumer needs and preferences, coupled with a commitment to rigorous scientific testing and adherence to the highest quality standards. Through strategic partnerships and acquisitions, Sanofi Consumer Healthcare Inc. expands its reach and reinforces its position as a leader in the consumer healthcare industry. The company prides itself on fostering a culture of innovation and collaboration, attracting top talent and nurturing a passion for improving people's lives. Sanofi Consumer Healthcare Inc.'s distribution network spans across multiple channels, including retail pharmacies, supermarkets, drug stores, and e-commerce platforms, ensuring convenient access to its products for consumers across diverse demographics. The company invests significantly in marketing and educational initiatives to raise awareness about its brands and empower consumers to make informed choices about their health. With a strong emphasis on ethical and responsible business practices, Sanofi Consumer Healthcare Inc. is dedicated to building long-term relationships with its customers, partners, and stakeholders, contributing to the overall well-being of communities around the globe. The company's commitment extends beyond providing effective healthcare solutions; it encompasses a dedication to sustainability and corporate social responsibility.
Company Details
Key Leadership
SANOFICONR Share Price: Frequently Asked Questions
What is the current share price of Sanofi Consumer Healthcare India Limited?
Sanofi Consumer Healthcare India Limited (SANOFICONR) trades at ₹3990.40 on NSE and BSE. Market cap ₹9.18K (Cr). Educational data only.
What is the P/E ratio of Sanofi Consumer Healthcare India Limited?
Sanofi Consumer Healthcare India Limited has a P/E of 34.55x vs industry average 34.89x.
What is the Bull Run score for Sanofi Consumer Healthcare India Limited?
Sanofi Consumer Healthcare India Limited has a Bull Run score of 52.2/100 based on 25+ financial parameters.
Does Sanofi Consumer Healthcare India Limited pay dividends?
Sanofi Consumer Healthcare India Limited has a dividend yield of 1.66%. Past dividends don't guarantee future payments.
What is the ROE of Sanofi Consumer Healthcare India Limited?
Sanofi Consumer Healthcare India Limited has ROE of 73.09%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Sanofi Consumer Healthcare India Limited?
Sanofi Consumer Healthcare India Limited has debt-to-equity of 0.00.
Is Sanofi Consumer Healthcare India Limited a good investment?
Bull Run gives Sanofi Consumer Healthcare India Limited a score of 52.2/100. This is not investment advice — consult a SEBI-registered advisor.